High-dose ursodeoxycholic acid in primary sclerosing cholangitis a randomised double-blind placebo-controlled trial

被引：0
|
作者：
Bansi, D
Christie, J
Fleming, K
Chapman, R
机构：
[1] JOHN RADCLIFFE HOSP, DEPT GASTROENTEROL, OXFORD OX3 9DU, ENGLAND
[2] JOHN RADCLIFFE HOSP, NUFFIELD DEPT PATHOL, OXFORD OX3 9DU, ENGLAND
来源：
GASTROENTEROLOGY | 1996年 / 110卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A1146 / A1146
页数：1
相关论文
共 50 条
  • [1] URSODEOXYCHOLIC ACID IN PRIMARY SCLEROSING CHOLANGITIS - A DOUBLE-BLIND PLACEBO CONTROLLED TRIAL
    LO, SK
    HERRMANN, R
    CHAPMAN, RW
    FLEMING, KA
    SHEARMAN, J
    CUSICK, P
    DOOLEY, JS
    [J]. HEPATOLOGY, 1992, 16 (04) : A92 - A92
  • [2] RANDOMIZED, DOUBLE-BLIND CONTROLLED TRIAL OF HIGH-DOSE URSODEOXYCHOLIC ACID (UCDA) FOR PRIMARY SCLEROSING CHOLANGITIS (PSC)
    Lindor, Keith D.
    Enders, Felicity B.
    Schmoll, Jeffrey A.
    Hoskin, Tanya L.
    Jorgensen, Roberto A.
    Petz, Janice L.
    Keach, Jill C.
    Kowdley, Kris V.
    Mooney, Jody C.
    Luketic, Velimir A.
    Sargeant, Carol C.
    Harrison, M. Edwyn
    Braaten, Julie K.
    McCashland, Timothy M.
    Bernord, Tamara
    Befeler, Alex
    King, Debra L.
    Harnois, Denise M.
    Miceli, Ellen L.
    [J]. HEPATOLOGY, 2008, 48 (04) : 378A - 378A
  • [3] High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double-blind, placebo-controlled trial.
    Mitchell, SA
    Bansi, D
    Hunt, N
    Christie, J
    Fleming, K
    Chapman, R
    [J]. GUT, 1997, 40 : TH115 - TH115
  • [4] High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double-blind, placebo-controlled trial.
    Mitchell, S
    Bansi, D
    Hunt, N
    Christie, J
    Fleming, K
    Chapman, R
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : A1335 - A1335
  • [5] Fenofibrate in primary sclerosing cholangitis; a randomized, double-blind, placebo-controlled trial
    Hatami, Behzad
    Mosala, Mozhde
    Hassani, Amir Hossein
    Ardakani, Mohammad Javad Ehsani
    Gholami, Samira
    Zali, Mohammad Reza
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2022, 10 (04):
  • [6] URSODEOXYCHOLIC ACID FOR TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS - A PLACEBO-CONTROLLED TRIAL
    BEUERS, U
    SPENGLER, U
    KRUIS, W
    AYDEMIR, U
    WIEBECKE, B
    HELDWEIN, W
    WEINZIERL, M
    PAPE, GR
    SAUERBRUCH, T
    PAUMGARTNER, G
    [J]. HEPATOLOGY, 1992, 16 (03) : 707 - 714
  • [7] High-Dose Ursodeoxycholic Acid Therapy for Nonalcoholic Steatohepatitis: A Double-Blind, Randomized, Placebo-Controlled Trial
    Leuschner, Ulrich F. H.
    Lindenthal, Birgit
    Herrmann, Guenter
    Arnold, Joachim C.
    Roessle, Martin
    Cordes, Hans-Joerg
    Zeuzem, Stefan
    Hein, Jasper
    Berg, Thomas
    [J]. HEPATOLOGY, 2010, 52 (02) : 472 - 479
  • [8] A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis
    Mitchell, SA
    Bansi, DS
    Hunt, N
    von Bergmann, K
    Fleming, KA
    Chapman, RW
    [J]. GASTROENTEROLOGY, 2001, 121 (04) : 900 - 907
  • [9] Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis:: A randomized placebo-controlled trial
    Färkkilä, M
    Karvonen, AL
    Nurmi, H
    Nuutinen, H
    Taavitsainen, M
    Pikkarainen, P
    Kärkkäinen, P
    [J]. HEPATOLOGY, 2004, 40 (06) : 1379 - 1386
  • [10] Randomised clinical trial: high-dose acid suppression for chronic cough - a double-blind, placebo-controlled study
    Shaheen, N. J.
    Crockett, S. D.
    Bright, S. D.
    Madanick, R. D.
    Buckmire, R.
    Couch, M.
    Dellon, E. S.
    Galanko, J. A.
    Sharpless, G.
    Morgan, D. R.
    Spacek, M. B.
    Heidt-Davis, P.
    Henke, D.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (02) : 225 - 234
12345